Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth1

Background: It is well established that low birth weight and accelerated postnatal growth increase the risk of liver dysfunction in later life. However, molecular mechanisms underlying such developmental programming are not well characterized, and potential intervention strategies are poorly defined. Objectives: We tested the hypotheses that poor maternal nutrition and accelerated postnatal growth would lead to increased hepatic fibrosis (a pathological marker of liver dysfunction) and that postnatal supplementation with the antioxidant coenzyme Q10 (CoQ10) would prevent this programmed phenotype. Design: A rat model of maternal protein restriction was used to generate low-birth-weight offspring that underwent accelerated postnatal growth (termed “recuperated”). These were compared with control rats. Offspring were weaned onto standard feed pellets with or without dietary CoQ10 (1 mg/kg body weight per day) supplementation. At 12 mo, hepatic fibrosis, indexes of inflammation, oxidative stress, and insulin signaling were measured by histology, Western blot, ELISA, and reverse transcriptase–polymerase chain reaction. Results: Hepatic collagen deposition (diameter of deposit) was greater in recuperated offspring (mean ± SEM: 12 ± 2 μm) than in controls (5 ± 0.5 μm) (P < 0.001). This was associated with greater inflammation (interleukin 6: 38% ± 24% increase; P < 0.05; tumor necrosis factor α: 64% ± 24% increase; P < 0.05), lipid peroxidation (4-hydroxynonenal, measured by ELISA: 0.30 ± 0.02 compared with 0.19 ± 0.05 μg/mL per μg protein; P < 0.05), and hyperinsulinemia (P < 0.05). CoQ10 supplementation increased (P < 0.01) hepatic CoQ10 concentrations and ameliorated liver fibrosis (P < 0.001), inflammation (P < 0.001), some measures of oxidative stress (P < 0.001), and hyperinsulinemia (P < 0.01). Conclusions: Suboptimal in utero nutrition combined with accelerated postnatal catch-up growth caused more hepatic fibrosis in adulthood, which was associated with higher indexes of oxidative stress and inflammation and hyperinsulinemia. CoQ10 supplementation prevented liver fibrosis accompanied by downregulation of oxidative stress, inflammation, and hyperinsulinemia.

[1]  S. Eghtesadi,et al.  Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial , 2015, Nutritional neuroscience.

[2]  Dan Zhou,et al.  Pathophysiological basis for compromised health beyond generations: role of maternal high-fat diet and low-grade chronic inflammation. , 2015, The Journal of nutritional biochemistry.

[3]  S. Ozanne,et al.  Nutritional programming of coenzyme Q: potential for prevention and intervention? , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Farhangi,et al.  Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. , 2014, Archives of medical research.

[5]  T. Auguet,et al.  Molecular pathways in non-alcoholic fatty liver disease , 2014, Clinical and experimental gastroenterology.

[6]  Effect of maternal protein restriction on liver metabolism in rat offspring , 2014, The Journal of Physiological Sciences.

[7]  S. Rahman,et al.  Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells. , 2014, The international journal of biochemistry & cell biology.

[8]  G. Yeo,et al.  Maternal diet amplifies the hepatic aging trajectory of Cidea in male mice and leads to the development of fatty liver , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Hokken-Koelega,et al.  Accelerated infant weight gain and risk for nonalcoholic fatty liver disease in early adulthood. , 2014, The Journal of clinical endocrinology and metabolism.

[10]  S. Ozanne,et al.  The impact of early nutrition on the ageing trajectory , 2014, Proceedings of the Nutrition Society.

[11]  S. Ozanne,et al.  Coenzyme Q10 prevents accelerated cardiac aging in a rat model of poor maternal nutrition and accelerated postnatal growth. , 2013, Molecular metabolism.

[12]  C. Aiken,et al.  Suboptimal nutrition in utero causes DNA damage and accelerated aging of the female reproductive tract , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Monteduro,et al.  Nonalcoholic Fatty Liver Disease in Prepubertal Children Born Small for Gestational Age: Influence of Rapid Weight Catch-Up Growth , 2013, Hormone Research in Paediatrics.

[14]  S. Friedman,et al.  Therapy for Fibrotic Diseases: Nearing the Starting Line , 2013, Science Translational Medicine.

[15]  E. Camm,et al.  Developmental Programming of Cardiovascular Dysfunction by Prenatal Hypoxia and Oxidative Stress , 2012, PloS one.

[16]  S. Ozanne,et al.  Mechanisms of early life programming: current knowledge and future directions. , 2011, The American journal of clinical nutrition.

[17]  K. Iwaisako,et al.  The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice , 2011, Hepatology.

[18]  Á. Valverde,et al.  Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. , 2011, Journal of hepatology.

[19]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[20]  S. Friedman,et al.  Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. , 2010, Gastroenterology.

[21]  R. Simmons,et al.  Maternal Antioxidant Supplementation Prevents Adiposity in the Offspring of Western Diet–Fed Rats , 2010, Diabetes.

[22]  Patrice D Cani,et al.  Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. , 2009, Biochemical pharmacology.

[23]  Yuba Raj Pokharel,et al.  Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. , 2009, Toxicology and applied pharmacology.

[24]  A. Alisi,et al.  Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. , 2008, Pediatric endocrinology reviews : PER.

[25]  Hui Wang,et al.  Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies , 2008, Journal of Gastroenterology.

[26]  K. Fujii,et al.  Safety assessment of coenzyme Q10 (CoQ10) , 2008, BioFactors.

[27]  P. Pladys,et al.  Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  Yuanping Han Matrix metalloproteinases, the pros and cons, in liver fibrosis , 2006, Journal of gastroenterology and hepatology.

[29]  H. Ikematsu,et al.  Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. , 2006, Regulatory toxicology and pharmacology : RTP.

[30]  G. Dallner,et al.  Metabolism and function of coenzyme Q. , 2004, Biochimica et biophysica acta.

[31]  I. Leclercq,et al.  Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. , 2003, Journal of hepatology.

[32]  Gary Fiskum,et al.  Generation of reactive oxygen species by the mitochondrial electron transport chain , 2002, Journal of neurochemistry.

[33]  D. Barker,et al.  The thrifty phenotype hypothesis. , 2001, British medical bulletin.

[34]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[35]  Jang-Soo Chun,et al.  Tumor Necrosis Factor-α Generates Reactive Oxygen Species via a Cytosolic Phospholipase A2-linked Cascade* , 2000, The Journal of Biological Chemistry.

[36]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[37]  H. Huhtala,et al.  The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice , 1998, Biochemistry and molecular biology international.

[38]  B. Reusens,et al.  Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. , 1990, Biology of the neonate.

[39]  F. Bianchi,et al.  Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[40]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[41]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.